{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T20:45:34Z","timestamp":1770065134066,"version":"3.49.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Hematology"],"published-print":{"date-parts":[[2007,6,1]]},"DOI":"10.1532\/ijh97.e0620","type":"journal-article","created":{"date-parts":[[2007,6,19]],"date-time":"2007-06-19T21:38:59Z","timestamp":1182289139000},"page":"408-414","source":"Crossref","is-referenced-by-count":43,"title":["Cardiac Toxicity of High-Dose Cyclophosphamide in Patients with Multiple Myeloma Undergoing Autologous Hematopoietic Stem Cell Transplantation"],"prefix":"10.1007","volume":"85","author":[{"given":"Samo","family":"Zver","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vesna","family":"Zadnik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matjaz","family":"Bunc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Polona","family":"Rogel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Cernelc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirta","family":"Kozelj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"E00001","unstructured":"Attal M, Harousseau J-L, Stoppa A-M, et al, for The Intergroupe Fran\u00e7ais du My\u00e9lome. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. <i>N Engl J Med.<\/i> 1996;335:91-97."},{"key":"E00002","unstructured":"Child JA, Gareth JM, Davies FE, et al. High dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma. <i>N Engl J Med.<\/i> 2003;348:1875-1883."},{"key":"E00003","unstructured":"Barlogie B, Jagannath S, Vesole DH, et al. Superiority of tandem autologous transplantation over standard therapy for previously untreated multiple myeloma. <i>Blood.<\/i> 1997;89:789-793."},{"key":"E00004","unstructured":"Attal M, Harousseau J-L, Facon T, et al, for the InterGroupe Francophone du My\u00e9lome. Single versus double autologous stemcell transplantation for multiple myeloma. <i>N Engl J Med.<\/i> 2003;349:2495-2502."},{"key":"E00005","unstructured":"Kupari M, Volin L, Soukas A, Hekali P, Ruutu T. Cardiac involvement in bone marrow transplantation: serial changes in left ventricular size, mass and performance. <i>J Intern Med.<\/i> 1990;227:259-266."},{"key":"E00006","unstructured":"Bearman SI, Appelbaum FR, Buckner CD, et al. Regimen-related toxicity in patients undergoing bone marrow transplantation. <i>J Clin Oncol.<\/i> 1998;6:1562-1568."},{"key":"E00007","unstructured":"Auner HW, Tinchon C, Brezinschek RI, et al. Monitoring of cardiac function by serum cardiac troponin T levels, ventricular repolarisation indices, and echocardiography after conditioning with fractionated total body irradiation and high-dose cyclophosphamide. <i>Eur J Haematol.<\/i> 2002;69:1-6."},{"key":"E00008","unstructured":"Mori T, Yanagi N, Moruyama T, et al. Left ventricular diastolic dysfunction induced by cyclophosphamide in blood stem cell transplantation. <i>Jpn Heart J.<\/i> 2002;43:249-261."},{"key":"E00009","unstructured":"Appleton CP, Firstenberg MS, Garcia MJ, Thomas JD. The echo-Doppler evaluation of left ventricular diastolic function: a current prospective. <i>Cardiol Clin.<\/i> 2000;18:513-546."},{"key":"E00010","unstructured":"Goldberg MA, Antin JH, Guinan EC, Rappeport JM. Cyclophosphamide cardiotoxicity: an analysis of dosing as a risk factor. <i>Blood.<\/i> 1986;68:1114-1118."},{"key":"E00011","unstructured":"Sparano JA, Brown DL, Wolff AC. Predicting cancer therapyinduced cardiotoxicity: the role of troponins and other markers. <i>Drug Saf.<\/i> 2002;25:301-311."},{"key":"E00012","doi-asserted-by":"crossref","unstructured":"Morjana NA. Degradation of human cardiac troponin I after myocardial infarction. <i>Biotechnol Appl Biochem.<\/i> 1998;28:105-111.","DOI":"10.1111\/j.1470-8744.1998.tb00519.x"},{"key":"E00013","doi-asserted-by":"crossref","unstructured":"Klootwijk P, Hamm C. Acute coronary syndromes: diagnosis. <i>Lancet.<\/i> 1999;353(suppl 2):SII10-SII15.","DOI":"10.1016\/S0140-6736(99)90235-0"},{"key":"E00014","unstructured":"Cardinale D, Sandri MT, Colombo A, et al. Prognostic value of troponin I in cardiac risk stratification of cancer patients undergoing high-dose chemotherapy. <i>Circulation.<\/i> 2004;109:2749-2754."},{"key":"E00015","unstructured":"Valli N, Gobinet A, Bordenave L. Review of 10 years of the clinical use of brain natriuretic peptide in cardiology. <i>J Lab Clin Med.<\/i> 1999;134:437-444."},{"key":"E00016","unstructured":"Cowburn PJ, Cleland JGF. Endothelin antagonists for chronic heart failure: do they have a role? <i>Eur Heart J.<\/i> 2001;22:1772-1784."},{"key":"E00017","unstructured":"Luescher TF, Barton M. Endothelins and endothelin receptors antagonists: therapeutic considerations for a novel class of cardiovascular drugs. <i>Circulation.<\/i> 2000;102:2434-2440."},{"key":"E00018","unstructured":"Benvenuto GM, La Vecchia L, Morandi P, Ruffini PA, Mezzena G. Assessment of cardiotoxicity of high dose cyclophosphamide with electrocardiographic, echocardiographic, and troponin I monitoring in patients with breast tumors [in Italian]. <i>Ital Heart J Suppl.<\/i> 2000;1:1457-1463."},{"key":"E00019","unstructured":"Lahtinen R, Kuikka J, Nousiainen T, Uusitupa M, Lansimies E. Cardiotoxicity of epirubicin and doxorubicin: a double blind randomised study. <i>Eur J Haematol.<\/i> 1991;46:301-305."},{"key":"E00020","unstructured":"Pai VB, Nahata MC. Cardiotoxicity of chemotherapeutic agents: incidence, treatment and prevention. <i>Drug Saf.<\/i> 2000;22:263-302."},{"key":"E00021","unstructured":"Ryberg M, Nielsen D, Skovsgaard T, Hansen J, Jensen BV. Epirubicin cardiotoxicity: an analysis of 469 patients with metastatic breast cancer. <i>J Clin Oncol.<\/i> 1998;16:3502-3508."},{"key":"E00022","unstructured":"Buja LM, Ferrans VJ, Graw RG Jr. Cardiac pathologic findings in patients treated with bone marrow transplantation. <i>Human Pathol.<\/i> 1976;7:17-45."},{"key":"E00023","unstructured":"Gottdiener JS, Appelbaum FR, Ferrans VJ, Deisseroth A, Ziegler J. Cardiotoxicity associated with high-dose cyclophosphamide therapy. <i>Arch Intern Med.<\/i> 1981;141:758-763."},{"key":"E00024","doi-asserted-by":"crossref","unstructured":"Antman EM. Decision making with cardiac troponin tests. <i>N Engl J Med.<\/i> 2002;346:2079-2082.","DOI":"10.1056\/NEJMe020049"},{"key":"E00025","unstructured":"Mark DB, Felker M. B-type natriuretic peptide: a biomarker for all seasons. <i>N Engl J Med.<\/i> 2004;350:718-720."},{"key":"E00026","unstructured":"Wang TJ, Larson MG, Levy D, et al. Plasma natriuretic peptide levels and the risk of cardiovascular events and death. <i>N Engl J Med.<\/i> 2004;350:655-663."},{"key":"E00027","unstructured":"Nousianen T, Vanninen E, Jantunen E, et al. Natriuretic peptides during the development of doxorubicin-induced left ventricular diastolic dysfunction. <i>J Intern Med.<\/i> 2002;251:228-234."},{"key":"E00028","unstructured":"Seino Y, Ogawa A, Yamashita T, et al. Application of NT-proBNP and BNP measurements in cardiac care: a more discerning marker for the detection and evaluation of heart failure. <i>Eur J Heart Fail.<\/i> 2004;6:295-300."},{"key":"E00029","unstructured":"Levin ER. Endothelins. <i>N Engl J Med.<\/i> 1995;333:356-361."},{"key":"E00030","unstructured":"Nakamura S, Naruse M, Naruse K, Demura H, Uemura H. Immunocytochemical localization of endothelin in cultured bovine endothelial cells. <i>Histochemistry.<\/i> 1990;94:475-477."},{"key":"E00031","unstructured":"Wei CM, Lerman A, Rodeheffer RJ, et al. Endothelin in human congestive heart failure. <i>Circulation.<\/i> 1994;89:1580-1586."},{"key":"E00032","unstructured":"Giannuzzi P, Temporelli PL, Bossimi E, et al. Independent and incremental prognostic value of Doppler-derived mitral deceleration time of early filling in both symptomatic and asymptomatic patients with left ventricular dysfunction. <i>J Am Coll Cardiol.<\/i> 1996;28:383-390."},{"key":"E00033","unstructured":"Benvenuto GM, Ometto R, Fontanelli A, et al. Chemotherapyrelated cardiotoxicity: new diagnostic and preventive strategies. <i>Ital Heart J.<\/i> 2003;10:655-667."},{"key":"E00034","unstructured":"Suzuki J, Yanagisawa A, Shigeyama T, et al. Early detection of anthracycline-induced cardiotoxicity by radionuclide angiocardiography. <i>Angiology.<\/i> 1999;50:37-45."},{"key":"E00035","unstructured":"Morandi P, Ruffini PA, Benvenuto GM, La Vecchia L, Mezzena G, Raimondi R. Serum cardiac troponin I levels and ECG\/Echo monitoring in breast cancer patients undergoing high-dose (7 g\/m<sup>2<\/sup>) cyclophosphamide. <i>Bone Marrow Transplant.<\/i> 2001;28:277-282."},{"key":"E00036","unstructured":"Venge P, Johnston N, Lagerquist B, Wallentin L, Lindahl B, and the FRISC-II Study Group. Clinical and analytical performance of the Liaison cardiac troponin I assay in unstable coronary artery disease and the impact of age on the definition of reference limits: a FRISC-II Substudy. <i>Clin Chem.<\/i> 2003;49:880-886."},{"key":"E00037","unstructured":"Sagnella GA. Measurement and significance of circulating natriuretic peptides in cardiovascular disease. <i>Clin Sci (Lond).<\/i> 1998;95:519-529."},{"key":"E00038","unstructured":"Okishima N, Hajiwara Y, Seito T, Yano M, Kido H. Specific sandwich-type enzyme immunoassays for smooth muscle constricting novel 31-amino acid endothelins. <i>Biochem Biophys Res Commun.<\/i> 1999;256:1-5."},{"key":"E00039","unstructured":"Teichholz LE, Kreulen T, Herman MV, Gorlin R. Problems in echocardiographic volume determinations: echocardiographicangiographic correlations in the presence of absence of asynergy. <i>Am J Cardiol.<\/i> 1976;37:7-11."},{"key":"E00040","unstructured":"Lewis JF, Kuo LC, Nelson JG, Limacher MC, Quinones MA. Pulsed Doppler echocardiographic determination of stroke volume and cardiac output: clinical validation of two new methods using the apical window. <i>Circulation.<\/i> 1984;70:425-431."}],"container-title":["International Journal of Hematology"],"original-title":[],"link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1532\/IJH97.E0620","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T04:58:42Z","timestamp":1707973122000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1532\/IJH97.E0620"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6,1]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,6,1]]}},"alternative-id":["R67016L4J7821HN3"],"URL":"https:\/\/doi.org\/10.1532\/ijh97.e0620","relation":{},"ISSN":["0925-5710"],"issn-type":[{"value":"0925-5710","type":"print"}],"subject":[],"published":{"date-parts":[[2007,6,1]]}}}